Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Multicenter Trial for Anti-adhesion Effect of GUARDIX-SGⓇ Following Radical Gastrectomy in Patients With Gastric Cancer.

NCT02198898 is registered in ClinicalTrials.gov with The Catholic University of Korea as lead sponsor.

NCT NCT02198898
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02198898 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Multicenter Trial for Anti-adhesion Effect of GUARDIX-SGⓇ Following Radical Gastrectomy in Patients With Gastric Cancer.
Lead sponsor
The Catholic University of Korea
Phase
Phase 3
Overall status
Unknown status
Start date
July 31, 2013
Completion date
August 31, 2017
Enrollment
224 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adhesive intestinal obstruction